Article
A novel glutamine metabolism-related gene signature for prognostic prediction in patients with lung adenocarcinoma
2022-06-08
Abstract excerpt
<title>Abstract</title> <p>Background Lung adenocarcinoma (LUAD) is the major non-small-cell lung cancer pathological subtype with poor prognosis worldwide. Glutamine metabolism (GM) plays an important role in tumor development and progression. Herein, we aimed to construct a GM-associated prognostic gene signature to predict survival in patients with LUAD. Methods The gene expression profiles of patients with...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e48ba94a-a24d-5f2a-aa0a-ea59c0ef2f7f
- DOI
- 10.21203/rs.3.rs-1708815/v1
